Background {#Sec1}
==========

Nature has developed an enormous diversity during several billion years of evolution. The Mediterranean Area represents one of the world's major centers of animal diversity; with around 20 gorgonian species, four belong to the genus *Eunicella*: *E. verrucosa*, *E. filiformis*, *E. cavolini* and *E. singularis* \[[@CR1]\].

Although natural compounds have been replaced by synthetic chemistry as the main source of new drugs, marine invertebrates remain an unequalled source of biochemical diversity. The studies on gorgonian have great importance in the research of marine resources of active compounds mainly by the pharmaceutical industry or for other uses. In fact, the gorgonians (Anthozoa, Gorgonacea) are known for possessing a wide range of pharmacologic and health promoting properties including antibacterial \[[@CR2]\], antiviral \[[@CR3]\], antiplasmodial \[[@CR4]\], antifouling \[[@CR5]\], antiproliferative \[[@CR6]\], cytotoxic \[[@CR7]\] and insecticidal \[[@CR8]\] effects. The gorgonian of the genus *Eunicella* has been demonstrated to contain a wide variety of natural products as steroids and diterpenes \[[@CR9],[@CR10]\]. These compounds posses anticancer, gastroprotective and anti-inflammatory activities \[[@CR11]\]. For many years, our marine pharmacological group in Tunisia has been involved in an accurate research program on gorgonian constituents in order to define both their chemical composition and their biological activities. On the other hand, the use of non-steroidal anti-inflammatory drugs (NSAID) for the treatment of inflammatory diseases is associated with adverse effects as peptic ulcer \[[@CR12]\]. Therefore, the research of potent anti-inflammatory drugs from natural sources and with fewer side effects had become necessary. This study has yielded the anti-inflammatory and gastroprotective effects of the organic extract and its semi-purified fractions of the white gorgonian *Eunicella singularis* (Esper, 1791). The structure elucidation of the isolated compounds from the active fraction was done by 1D and 2D NMR experiments and by comparison with literature data.

Methods {#Sec2}
=======

General procedures {#Sec3}
------------------

HPLC was performed using a Waters model 510 pump equipped with Waters Rheodine injector and a differential refractometer, model 401. Medium pressure liquid chromatography (MPLC) was performed on a Buchi apparatus using a silica gel (230--400 mesh) column.

NMR spectra were obtained on Varian Inova 400 and Varian Inova 500 NMR spectrometers (^1^H at 400 and 500 MHz, ^13^C at 100 and 125 MHz, respectively) equipped with a Sun hardware, δ (ppm), *J* in hertz, and spectra referred to CD~3~Cl~3~ (δH=7.27; δC= 70.0 ) as internal standard. High-resolution ESIMS spectra were performed with a Micromass QTOF Micro mass spectrometer. All reagents were commercially obtained (Aldrich, Fluka) at the highest commercial quality and used without further purification except where noted. All reactions were monitored by TLC on silica gel plates (Macherey--Nagel). Carrageenan (BDH Chemicals Ltd Poole England), Acetylsalicylate of Lysine (ASL) were purchased from Sigma Chemical (Berlin, Germany). Ranitidine was obtained from Medis (Tunis, Tunisia), omeprazole was obtained from AstraZeneca (Monts).

Collection and extraction {#Sec4}
-------------------------

*E. singularis* was collected from the Mediterranean Sea in various areas of the coastal region of Tabarka (Tunisia), in June 2010, at a depth between 20 and 30 m. Identification of specimens was carried out in the National Institute of Marine Sciences and Technologies (Salamboo, Tunisia) where a voucher specimen of *E. singularis* was deposited under the following reference 1132. After maceration of 600 g of the powdered material with methanol and dichloromethane (1:1, v/v) for 48h three times, the organic extract (40 g) was purified, using C18 cartridges (Sep-pack, Supelco), by gradient elution with different organic solvents in the order of decreased polarity: ethanol, acetone and methanol/CH~2~Cl~2~ (1:1) to give three semi-purified fractions: ethanol (F-EtOH), acetone (F-Ac) and methanol/CH~2~Cl~2~ (F-MeOH/CH~2~Cl~2~) fractions. Organic solvents were removed from recuperated fractions using rotating evaporator at 40°C.

Purification, isolation and structure elucidation {#Sec5}
-------------------------------------------------

F-EtOH (15 g) was fractionated according to the Kupchan partitioning procedure \[[@CR13]\] as follow: the ethanolic fraction was dissolved in a mixture of MeOH/H~2~O containing 10% H~2~O and partitioned against *n*-hexane to give 10.3 g of the crude extract. The water content (% v/v) of the MeOH extract was adjusted to 30% and partitioned against CHCl~3~ to give 3.9 g of the crude extract. The aqueous phase was concentrated to remove MeOH and then extracted with *n*-BuOH (268 mg of crude extract) (Figure [1](#Fig1){ref-type="fig"}). The *n*-hexane extract (5 g) was fractioned by silica gel MPLC using a solvent gradient system from CH~2~Cl~2~ to MeOH. Fraction eluted with CH~2~Cl~2~: MeOH 99:1 (307 mg) was purified by HPLC on a Nucleodur 100--5 C18 (5 μm; 10 mm i.d. × 250 mm) with 99% MeOH: H~2~O as eluent (flow rate 3mL/min) to give 1.3 mg of 5α-cholest-5-en-3β-ol (**1**) (t~R~=55 min) and 2.4 mg of 24-ethylcholesta-5, 22-dien-3β-ol (**3**) (t~R~=83min) (Figure [1](#Fig1){ref-type="fig"}).Figure 1**Purification and separation process of the isolation of six compounds from the ethanolic fraction from** ***E. singularis.***

Fraction eluted with CH~2~Cl~2~:MeOH 95:5 (288 mg) was purified by HPLC on a Nucleodur 100--5 C18 (5 μ, 4.6 mm i.d. × 250 mm) with 95% MeOH:H~2~O as eluent (flow rate 1 mL/min) to give 0.1 mg of ergosta-5,22-dien-3β-ol (**2**) (t~R~=74 min) (Figure [1](#Fig1){ref-type="fig"}).

The CHCl~3~ extract (3.9 g) was chromatographed by silica gel MPLC using a solvent gradient system from CH~2~Cl~2~ to CH~2~Cl~2~: MeOH 1:1.

Fraction eluted with CH~2~Cl~2~: MeOH 95:5 (187.5 mg) was further purified by HPLC on a Nucleodur 100--5 C18 (5 μ, 4.6 mm i.d. × 250 mm) with 80% MeOH:H~2~O as eluent (flow rate 1 mL/min) to give 0.3 mg of 5α,8α-epidioxyergosta 6,22-dien-3β-ol (**4**) (t~R~=29 min), and 0.6 mg of 3β-hydroxy-5α,8α-epidioxyergosta-6-ene (**5**) (t~R~=2 min) and 3 mg of palmonine D (**6**) (t~R~=3 min) (Figure [1](#Fig1){ref-type="fig"}).

The purities of compounds were determined to be greater than 95% by HPLC and NMR. Furthermore, HPLC chromatograms and spectroscopic data of each compound were reported (Additional file [1](#MOESM1){ref-type="media"}).

Pharmacological evaluation {#Sec6}
--------------------------

### Animals {#Sec7}

Wistar rats of either sex, weighing 150--200 g were obtained from Pasteur Institute (Tunis, Tunisia). Housing conditions and *in vivo* experiments were approved according to the guidelines established by the European Union on Animal Care (CCE Council 86/609).

### Carrageenan-Induced Rat Paw Edema {#Sec8}

The anti-inflammatory activity of the organic extract and its semi-purified fractions on carrageenan-induced paw edema was determined according to Winter et al. \[[@CR14]\]. The animals were divided into eleven groups of six rats each. The control group received an intraperitoneal (i.p.) dose of saline solution (NaCl 9g/L, 2.5 mL/kg), the reference group received Acetylsalicylate of Lysine (ASL) (300 mg/kg, i.p.), and the test groups received the organic extract of *E. singularis* (50, 100 and 200 mg/kg, i.p.) and its semi-purified fractions F-EtOH, F-Ac and F-MeOH/CH~2~Cl~2~ (25 and 50 mg/kg, i.p.). After 30 min, 0.05mL of a 1% carrageenan suspension was injected into the left hind paw. The paw volume up to the tibiotarsal articulation was measured using a plethysmometer (model 7150, Ugo Basile, Italy). The measures were determined at 0 h (V~0~) (before carrageenan injection) and 1, 3 and 5 h later (V~T~) (after carrageenan injection). Paw swelling was determined for each rat and the difference between V~T~ and V~0~ was taken as the edema value. The percentages of inhibition were calculated according to the following formula:$$\documentclass[12pt]{minimal}
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### Gastric lesions induced by HCl/ethanol {#Sec9}

The gastroprotective activity of the organic extract of *E. singularis* and its semi-purified fractions F-EtOH, F-Ac and F-MeOH/CH~2~Cl~2~ was studied in 150 mM HCl/EtOH induced gastric ulcer \[[@CR15]\]. Rats were divided into fifteen groups, fasted for 24 h prior receiving an intraperitoneal doses of vehicle (NaCl 9g/L, 2.5 mL/kg) for the control group, organic extract (50, 100 and 200 mg/kg, i.p.) and its semi-purified fractions F-EtOH, F-Ac and F-MeOH/CH~2~Cl~2~ (5, 10 and 25 mg/kg, i.p.) for the twelve test groups. Two other groups received ranitidine (60 mg/kg, i.p.) and omeprazole (30 mg/kg, i.p.) as reference drugs. After 30 min, all groups were orally treated with 1mL of 150 mM HCl/EtOH solution for gastric ulcer induction. Animals were killed 1 h after the administration of ulcerogenic agent, their stomachs were excised and opened along the great curvature, washed and stretched on cork plates. The surface was examined for the presence of lesions and the extent of the lesions was measured. The summative length of the lesions along the stomach was recorded (mm) as lesion index.

### Statistical analysis {#Sec10}

Data are presented as the mean±standard error (s.e.m). Statistical analysis was performed using Student's t-test. The significance of difference was considered to include values of P\<0.05.

Results and discussion {#Sec11}
======================

The current study was carried out to determine the in *vivo* anti-inflammatory and gastroprotective activities of the organic extract of *E. singularis* and its semi-purified fractions. The chemical composition of the more effective fraction was determined by both 1D and 2D NMR experiments.

As shown in Figure [2](#Fig2){ref-type="fig"}, 1D and 2D NMR analysis of the ethanolic fraction (F-EtOH) from the gorgonian *E. singularis* resulted in the identification of six compounds.Figure 2**Chemical structures of six compounds isolated from the white gorgonian** ***E. singularis*** **.** Five sterols **(1-5)**: 5α-cholest-5-en-3β-ol **(1)**; ergosta-5,22-dien-3β-ol **(2)**; 24- ethylcholesta-5,22-dien-3b-ol **(3)**; 5α,8α-epidioxyergosta 6,22-dien-3β-ol **(4)** and 3β-hydroxy- 5α,8α-epidioxyergosta-6-ene **(5);** and one diterpenoid: palmonine D **(6)**.

Compound **1** was isolated as colorless powder. The molecular formula was determined to be C~27~H~46~O. Analysis of ^1^H and ^13^C NMR data evidenced a Δ^5^ dihydroxy-steroid structure with a saturated C8 cholestane side chain. Comparison with literature data allowed assigning the 5α-cholest-5-ene-3β-ol (cholesterol) structure \[[@CR16]\].

Compound **2** has a molecular formula of C~28~H~46~O as determined by HRESIMS. Compound **2** was identified as ergosta-5,22-dien-3β-ol (ergosterol) \[[@CR17]\] (Figure [2](#Fig2){ref-type="fig"}). This compound was also isolated from the soft coral *Tubastraea coccinea* and *T. tagusensis* \[[@CR17]\].

Compound **3** was isolated as colorless powder. The molecular formula was determined to be C~28~H~46~O~.~ Its identity was determined by 1D and 2D NMR data as 24-ethylcholesta-5,22-dien-3b-ol (stigmasterol) earlier isolated from the halophyte *Salicornia herbacea* \[[@CR18]\] and then reported also from the plant *Aglaia eximia* \[[@CR19]\].

Compound **4** was isolated as white powder. The molecular formula was determined to be C~28~H~44~O~3~ by HRESIMS data. NMR data disclosed the 5α,8α-epidioxyergosta 6,22-dien-3β-ol structure. This compound was also isolated from the fungus *Sporothrix schenckii* \[[@CR20]\] and the fungus *Cryptoporus volvatus* \[[@CR21]\].

Compound **5** has a molecular formula of C~28~H~46~O~3~ as determined by HRESIMS. ^1^H and ^13^C NMR indicated that compound **5** is the Δ^22^ derivative of compound **4**. Therefore compound **5** was identified as 3β-hydroxy-5α,8α-epidioxyergosta-6-ene \[[@CR21]\].

Compound **6** was isolated as colorless oil. The molecular formula was determined to be C~24~H~36~O~6~ by HRESIMS. The analysis of ^1^H NMR spectrum clearly revealed an eunicellin diterpenoid structure. The ^13^C NMR spectrum revealed 24 carbon signals. ^1^H- and ^13^CNMR assignments were carried out with the aid of the detailed 2D analyses (COSY, HMQC, NOESY, and HMBC) and the resulting NMR evidence revealed **6** to be defined as palmonine D \[[@CR22]\]. Three sterols named 5α, 8α-epidioxysterols, pregnanes and 9,11-secosterols were separated from *E. cavolini*, another specie of the genus *Eunicella* \[[@CR10],[@CR11]\]. The five sterols identified in our study were isolated for the first time from *E. singularis* and were not yet found with another specie from this genus.

Palmonine D is also purified from *E. labiata*, another specie of the genus *Eunicella* \[[@CR22]\]. Other researchers reported the isolation of five diterpenoids from the gorgonian *E. labiata,* labiatamide A, labiatamide B, labiatin A, labiatin B and labiatin C \[[@CR23]\] but these compounds were not yet separated from *E. singularis*. Massileunicellin A, was obtained from *E. cavolini* \[[@CR24]\] but also was not identified from *E.singularis*.

The results reported in Figures [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"} showed the anti-inflammatory effects of organic extract and its semi-purified fractions from *E. singularis* administered intraperitoneally.Figure 3**Effect of intraperitoneal administration of the organic extract from** ***E. singularis*** **on the carrageenan-induced rat paw edema.** Values are mean ± SEM.Figure 4**Effect of intraperitoneal administration of semi-purified fractions (F-Ac, F-EtOH and F-MeOH/CH2Cl2 from** ***E. singularis*** **on the carrageenan-induced rat paw edema.** Values are mean ± SEM.

*E. singularis* organic extract presented a dose- related, statistically significant anti-inflammatory activity on carrageenan induced paw edema which was comparable with the reference drug, Acetylsalicylate of Lysine (ASL), a potent inhibitor of cyclooxygenase-2. The percent inhibition of edema at dose levels of 50, 100 and 200 mg/kg were 42.61%, 56.47% and 64.31% (at 3 h), respectively (Table [1](#Tab1){ref-type="table"}). The semi-purified fractions (F-Ac, F-EtOH, F-MeOH/CH~2~Cl~2~) were assessed for anti-inflammatory effect at 25 and 50 mg/kg. A dose-related anti-inflammatory property was observed for the three fractions with highly significant activity of F-EtOH at dose 50 mg/kg with a percentage of inhibition of 66.12% at 3 h. While F-Ac and F-MeOH/CH~2~Cl~2~ at a dose of 50 mg/kg reduced edema with a percentage of 50.22 and 54.78% (at 3 h), respectively. ASL as a reference standard drug inhibited the edema formation due to carrageenan to an extent of 56.32% (at 3 h) at the dose of 300 mg/kg. The development of edema induced by carrageenan corresponds to the events in the acute phase of inflammation mediated by histamine, bradykinin and prostaglandins produced under an effect of cyclooxygenase-2 (COX-2) \[[@CR25]\]. This enzyme is an inducible cyclooxygenase which boosts the inflammatory response by COX-2 mediated prostaglandin E~2~ (PGE~2~) \[[@CR26]\]. Hence, it is probably that the organic extract and its semi-purified fractions from the gorgonian *E. singularis* reduced inflammation by blocking the cyclooxygenase2 (COX-2). Morever, several studies reported that steroids isolated from other species of the genus *Eunicella* have anti-inflammatory activity such as secosteroids \[[@CR11]\]. The high anti-inflammatory activity of the fraction F-EtOH can be related with the presence of its main steroid constituents. The chemical analysis of this fraction (F-EtOH) revealed the presence of five sterols: 5α-cholest-5-en-3β-ol (cholesterol) **(1)**; ergosta-5,22-dien-3β-ol (ergosterol) **(2)**; 24-ethylcholesta-5,22-dien-3b-ol (stigmasterol) **(3)**; 5α,8α-epidioxyergosta 6,22-dien-3β-ol **(4)** and 3β-hydroxy-5α,8α-epidioxyergosta-6-ene **(5)**.Table 1**Anti-inflammatory effect of the intraperitoneal administration of** ***E. singularis*** **organic extract and its semi-purified fractions (F-EtOH, F-Ac and F-MeOH/CH** ~**2**~ **Cl** ~**2**~ **) and of reference drug (Acetylsalicylate of Lysine; ASL) in carrageenan-induced rat paw edema testTreatmentDose (mg/kg)Edema (10** ^**−2**^ **ml) (mean±s. e. m)Edema inhibition (%)1 h3 h5 h1 h3 h5 h**Vehicle-30.12±2.3855.35±3.358.5±4.69\-\--Organic extract5024.62±2.831.76±3.6\*\*35.14±4.1\*18.2642.6139.9210022.22±2.923.94±4.1\*\*27.95±1.5\*\*32.8456.4752.2120015.5±3.2\*19.75±2.4\*\*22.75±3.6\*\*48.5364.3161.11F-EtOH2519.73±1.642.74±2.751.26±2.634.4922.7812.365012.25±1.5\*\*18.75±2\*\*20.37±2.4\*\*59.3266.1265.17F-Ac2521.55±2.648.24±2.452.33±3.528.4212.8410.535020.63±2.427.55±3.2\*\*31.27±2.7\*31.4850.2246.54F-MeOH/CH~2~Cl~2~2522.85±3.239.67±2.644.2±4.824.1228.3224.435020.82±2.425.02±2.9\*\*34.79±3.4\*30.8654.7840.52ASL30019.66±3.424.17±2.7\*\*27.95±3.1\*\*34.7156.3252.22Values are expressed as mean±SEM; n=6 animals. \*P\<0.01, \*\*P\<0.001.

The gastroprotective effect of *E. singularis* organic extract and its semi-purified fractions against HCl/EtOH induced gastric damage in rats is shown in (Table [2](#Tab2){ref-type="table"}) and the results are comparable to that of the reference drugs ranitidine, histamine H~2~ receptor antagonist, and omeprazole, a proton pump inhibitor \[[@CR27]\]. Oral administration of HCl/EtOH produced gastric mucosal damage with severe hemorrhage with lesion index of 78.5 mm in the untreated group. Treatment of rats by organic extract of *E. singularis* produced a significant decrease in gastric hemorrhage and the lesion index was inhibited by 60, 68 and 75% at doses of 50, 100 and 200 mg/kg, respectively. The semi-purified fractions were assessed for gastroprotective activity at 5, 10 and 25 mg/kg. A dose-related gastroprotective effect was observed for the fractions F-EtOH and F-MeOH/CH~2~Cl~2~ with highly significant activity for the ethanolic fraction (F-EtOH) at 25 mg/kg. The lesion index was inhibited by 44, 52 and 70% at doses of 5, 10 and 25 mg/kg, respectively; while in the ranitidine treated animals (60 mg/kg) the inhibition was 65%. F-Ac failed to protect stomach tissues from mucosal damage. The two classical ulcer drugs ranitidine and omeprazole showed a significant activity with a percentage of inhibition of gastric lesions of 65 and 87%, respectively. Some reports on the gastroprotective effect of diterpenes belonging to different structural skeletons are published \[[@CR28]\]. In addition, another studies demonstrated that several terpenes or their derivatives posses gastroprotective activity in different models of induced gastric lesions in animals \[[@CR29]\]. This gastroprotective effect seems to be related with an increase of the defensive mechanisms of the stomach, such as prostaglandin synthesis and mucus production \[[@CR30]\]. Therefore, the involvement of diterpenoids palmonine D **6** isolated from the active fraction F-EtOH is hypothesized and can be responsible for its high activity.Table 2**Effect of** ***E. singularis*** **organic extract and its semi-purified fractions (F-EtOH, F-Ac, F-MeOH/CH** ~**2**~ **Cl** ~**2**~ **), and of reference drugs (ranitidine and omeprazol) on gastric ulcer induced by HCl/ethanol in ratsTreatmentDose (mg/kg)Ulcer index (mm)Inhibition (%)**Vehicle-78.5±3,49-Organic extract5031.52±2,42\*\*59.8410024.46±2,48\*\*68.8420019.49±3,48\*\*75.16F-EtOH543.36±1,52\*44.761037.20±3,05\*\*52.612523.33±1\*\*70.27F-Ac2561.97±0,721.05F-MeOH/CH~2~Cl~2~566.59±2,3315.171058.78±2,8225.112529.17±4,04\*\*62.84Ranitidine6027.47±2.3\*\*65Omeprazol309.78±0,81\*87.53Values are expressed as mean±SEM; n=6 animals. \*P\<0.01, \*\*P\<0.001.

Furthermore, various phenolic compounds (alkaloids, glycosides, and saponins) detected in *E. singularis* organic extract and fractions \[[@CR6]\] may be responsible for its activity. Several studies reported that alkaloids have anti-inflammatory and gastroprotective effects \[[@CR31]\]. Also, Glycosides, terpenoids and steroids detected in our samples are known to have anti-inflammatory and gastroprotective properties \[[@CR10],[@CR32]\] The synergic effect of different compounds of *E. singularis* ethanolic fraction may be responsible for its higher anti-inflammatory and gastroprotective activities. Furthermore, the high free radical scavenging activity of F-EtOH in the DPPH test \[[@CR6]\] suggests that the antioxidant activity may be one of the mechanisms of its gastroprotective and anti-inflammatory properties, because both ulcerous and inflammatory processes are related to an increase of free radicals \[[@CR33]\].

Conclusion {#Sec12}
==========

In conclusion, the obtained results demonstrated that the ethanolic fraction of *E. singularis* had the highest activity in the two tests (anti-inflammatory and gastroprotective). The structure elucidation of compounds isolated from this fraction revealed the presence of five sterols and a eunicellan-based diterpenoid which may be responsible for its activity.

Additional file {#Sec13}
===============

Additional file 1:**HPLC chromatograms and spectroscopic data of six compounds isolated from the white gorgonian** ***E. singularis.***
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